Palisade Bio (PALI) EPS (Basic) Growth (3y) (2013 - 2026)
Palisade Bio (PALI) EPS (Basic) Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 53.55% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 37.73% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.29% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -2.89% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 86.43% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Palisade Bio | 985.76 | -132.63 Mn | - | 81.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 81.53% |
| Dec 31, 2025 | 86.02% |
| Sep 30, 2025 | 82.30% |
| Jun 30, 2025 | 81.15% |
| Mar 31, 2025 | 86.32% |
| Dec 31, 2024 | 83.29% |
| Sep 30, 2024 | 76.90% |
| Jun 30, 2024 | 89.28% |
| Mar 31, 2024 | 83.27% |
| Dec 31, 2023 | 81.29% |
| Sep 30, 2023 | 74.72% |
| Jun 30, 2023 | 77.28% |
| Mar 31, 2023 | 81.74% |
| Dec 31, 2022 | 75.30% |
| Sep 30, 2022 | 72.37% |
| Jun 30, 2022 | 78.50% |
| Mar 31, 2022 | 75.44% |
| Dec 31, 2021 | 63.59% |
| Sep 30, 2021 | 75.11% |
| Jun 30, 2021 | 39.09% |